US Bancorp’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,559
| Closed | -$27K | – | 4309 |
|
|
2021
Q3 | $27K | Buy |
+4,559
| New | +$28.4K | ﹤0.01% | 2978 |
|
|
2019
Q1 | – | Sell |
-131
| Closed | -$1K | – | 3688 |
|
|
2018
Q4 | $1K | Hold |
131
| – | – | ﹤0.01% | 3550 |
|
|
2018
Q3 | $2K | Hold |
131
| – | – | ﹤0.01% | 3524 |
|
|
2018
Q2 | $3K | Hold |
131
| – | – | ﹤0.01% | 3458 |
|
|
2018
Q1 | $3K | Hold |
131
| – | – | ﹤0.01% | 3452 |
|
|
2017
Q4 | $3K | Hold |
131
| – | – | ﹤0.01% | 3437 |
|
|
2017
Q3 | $3K | Hold |
131
| – | – | ﹤0.01% | 3389 |
|
|
2017
Q2 | $3K | Hold |
131
| – | – | ﹤0.01% | 3353 |
|
|
2017
Q1 | $4K | Hold |
131
| – | – | ﹤0.01% | 3284 |
|
|
2016
Q4 | $2K | Hold |
131
| – | – | ﹤0.01% | 3404 |
|
|
2016
Q3 | $3K | Hold |
131
| – | – | ﹤0.01% | 3308 |
|
|
2016
Q2 | $2K | Buy |
+131
| New | +$1.65K | ﹤0.01% | 3420 |
|
US Bancorp's FLXN Position: Q4 2021 in Review
US Bancorp sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 4,559 shares — an estimated $27K sold.
US Bancorp first reported a position in FLXN in Q2 2016 and held it in 12 quarters. The position peaked at $27K in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- US Bancorp reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- US Bancorp sold 4,559 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $27K.
- US Bancorp first reported a position in Flexion Therapeutics, Inc. in Q2 2016 and held it in 12 quarters.
- US Bancorp's Flexion Therapeutics, Inc. position peaked at $27K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on US Bancorp's 13F filing for Q4 2021, filed 11 Feb 2022.